GLP-1 Drugs Associated With Smell and Taste Disruptions

New research suggests that people using glucagon-like peptide-1 (GLP-1) medications may have an increased risk of smell and taste disturbances. These medications are commonly used to treat diabetes and obesity. Taste and smell disorders are side effects that can negatively impact patients' quality of life. The research highlights the need for further investigation of this relationship. Patients taking GLP-1 medications should be informed about the possibility of these side effects. Healthcare providers should pay attention to cases of taste and smell disturbances in their patients taking these medications.